Wolverine (BPC-157 / TB-500)
Researched combination of BPC-157 and TB-500 for VEGFR2 signalling and actin dynamics studies
£21.00
Select Option
1
HPLC tested — COA available for every batch
Same-day dispatch before 2pm UK time
Discreet packaging · Delivery Protection available
A researched combination of two bioactive peptides: BPC-157 (a 15-amino acid partial sequence of gastric BPC protein) and TB-500 (a synthetic analogue of the Tβ4 actin-sequestering domain). Investigated in preclinical models for combined effects on VEGFR2-mediated angiogenesis and actin polymerisation dynamics. Used as a research tool in growth factor receptor and cytoskeletal biology studies.
Properties
| Appearance | White powder |
|---|---|
| Cas Number | N/A (Blend) |
| Form | Lyophilized powder |
| Heavy Metals | None Detected |
| Molecular Formula | N/A (Blend) |
| Molecular Weight | N/A (Blend) |
| Purity | ≥99% (HPLC) |
| Solubility | Refer to individual component solubility data. |
| Storage | Store in a dry environment away from direct sunlight. |
Certificate of Analysis by Constituent
GLOW Batch #WLV-2501Exp 2026-12-04
| Lot | Peptide | Expiry | Certificate of Analysis |
|---|---|---|---|
| WLV-2501B | TB-500 | 2026-12-04 | |
| WLV-2501A | BPC-157 | 2026-12-04 |
Customer Reviews
No reviews yet. Be the first to review this product!
Frequently Asked Questions
The Wolverine bundle combines BPC-157 and TB-500, two peptides extensively studied for tissue repair and regeneration. The name references the character known for rapid healing, reflecting the synergistic research focus of this combination on accelerated tissue recovery models.